OSM and neoplasm: A previous study showed that the chemokines from monocyte and the signals from tumor microenvironment contributed to the production of the pro‐metastatic factor oncostatin M by neutrophils, which may be potential targets of immune‐based anticancer treatment for HCC patients [41].